Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aviana Sinar Abadi Tbk. (IRSX) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Aviana Sinar Abadi Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Aviana Sinar Abadi Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Aviana Sinar Abadi Tbk. trades at Rp294 (market cap 1.66T, 124.08M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume). The key difference: Aviana Sinar Abadi Tbk. is far larger — about 2.9× UBC Medical Indonesia Tbk.'s market cap, and Aviana Sinar Abadi Tbk. is more actively traded (124.08M versus 3.48M). Which is the better fit depends on your goals.

IRSXLABS
Market Cap
1.66T576.7B
Volume
124.08M3.48M
Lot
1.24M34.82K
Turnover
35.62B522.79M
Average Price
287.1150.13
Value
35.62B522.79M
Indicative Equilibrium Price
294148
Indicative Equilibrium Volume
14.62K350

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IRSX
View details
LABS
View details

About Aviana Sinar Abadi Tbk.

PT Aviana Sinar Abadi Tbk (the Company) was established on December 17, 2013 based on Notarial Deed No. 15 of Isadora, S.H., M.Kn., notary in Jakarta. The Company started its commercial operations in 2013.

Read more on IRSX

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS